Handheld Devices for High Viscosity Injectables

handheld devices for high viscosity injectables   Handheld Devices for HV Injectables •  January 2017  •  No. HHV227K12  • US $2,850

Growth in high viscosity drugs is being driven by advances in biotechnology and host-vector engineering – advances that have led to a steady stream of biologics for a number of ailments and conditions. These powerful drugs come with a high cost-per-dose and the risk of significant side effects – factors that place an elevated emphasis on administration efficiency, safety and reliability. Many drugs in this class are characterized by physical properties and sensitivities that challenge the drug commercialization ecosystem. For example, monoclonal antibodies, perhaps the most significant category in terms of therapeutic and commercial importance, typically possess viscosities that are well above the normal limits of subcutaneous injection devices and techniques. Without a technical solution, these high viscosity drugs are formulated and supplied for infusion, a trend that threatens to put additional pressure on patient logistics and healthcare economics. Drug developers and device designers are increasingly working in collaboration to insure the commercial success of handheld devices for high viscosity injectables.


Bar_Graph  Injection Devices for High Viscosity Injectables Report Brochure (Download PDF)

Blue document  Injection Devices for High Viscosity Drugs Report Order Form (Download PDF)

Click Here to Order Online

Handheld Devices for High Viscosity Injectables – What You Will Learn

• What are the markets for therapeutic drugs with viscosities that cannot be delivered using standard self-injection devices and techniques?
• What are the technologies and devices that are aimed at positioning high viscosity drugs for subcutaneous injection?
• What are the design factors, material selection issues, formulation factors, and device capabilities and limitations of handheld devices that address the limitations of    high viscosity drugs?
• Who are the high viscosity injectable drug and device participants, their product development activities, business strategies, and corporate alliances and affiliations?
• What are the key therapeutic sectors for high viscosity injectables?
• What does the market for high viscosity injectables look like today? What will it be in 2022?
• What is the impact of economic, technology, and regulatory factors on high viscosity drugs that can be administered via handheld devices?

Handheld Devices for High Viscosity Injectables – Summary of Contents

Executive Summary

The Market Opportunity

High Viscosity Drug Market Dynamics
The Economics of Drug Delivery
Market Drivers
Growth of Biological Drugs
Demographics and Disease Prevalence
Innovation in Handheld Devices
Managed Care and Healthcare Economics
Competitive Landscape
Risk Factors

High Viscosity Injection Devices – Design Factors

Drug Properties
Drug Storage Requirements
Baseline Device Capabilities
Primary Packaging
Human Engineering/Ergonomics
Formulation Technology

High Viscosity Drugs – Addressable Markets

Biological Drugs (BLA)
Monoclonal Antibodies
Other HMW Biologicals
Intrinsic High Viscosity Drugs
Formulation-related High Viscosity
Sustained Release Injectables

Analysis of High Viscosity-Capable Handheld Devices

Specialty Glass Syringes
Specialty Autoinjectors
Specialty Pen Injectors
Needle-free Injectors
Cyclic Olefin Prefillable Syringes
Formulation-specific Devices

Near-term Therapeutic Sector Analysis

Therapy Sectors
Forecasts and Prospects

Market Factors

Regulatory Issues
Device Branding
Quality by Design
Ease of Use

Company Profiles


Useful Links

Viscosity, Injection Volume and Injection Flow Rate